Fenofibrate increases neuronal vasoconstrictor response in mesenteric arteries from diabetic rats: Role of noradrenaline, neuronal nitric oxide and calcitonin gene-related peptide

European Journal of Pharmacology

Volumn 666, Issue 1-3, 2011, Pages 142-149

  Del Campo, Lara ^a,b   Blanco Rivero, Javier ^a,b   Lfagon, Gloria ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

Author keywords

Calcitonin gene related peptide; Fenofibrate; Innervation; Nitric oxide; Noradrenaline; Rat mesenteric artery

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FENOFIBRATE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NORADRENALIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; UNCLASSIFIED DRUG;

ADRENERGIC NERVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CGRPERGIC INNERVATION; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROSTIMULATION; ENZYME PHOSPHORYLATION; INNERVATION; MALE; MESENTERIC ARTERY; NITRERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; STREPTOZOCIN DIABETES; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

EID: 79959961571     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.056     Document Type: Article

References (26)

1. M. Alvarez de Sotomayor, C. Mingorance, and R. Andriantsitohaina Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries Atherosclerosis 193 2007 112 120 (Pubitemid 46776716)
2. A. Bento-Abreu, A. Tabernero, and J.M. Medina Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons J. Neurochem. 103 2007 871 881 (Pubitemid 47568723)
3. J. Blanco-Rivero, R. Aras-Lopez, L. Del Campo, A. Sagredo, G. Balfagon, and M. Ferrer Orchidectomy increases beta-adrenoceptor activation-mediated neuronal nitric oxide and noradrenaline release in rat mesenteric artery Neuroendocrinology 84 2006 378 385 (Pubitemid 46474687)
4. J. Blanco-Rivero, I. Marquez-Rodas, F.E. Xavier, R. Aras-Lopez, I. Arroyo-Villa, M. Ferrer, and G. Balfagon Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway Cardiovasc. Res. 75 2007 398 407 (Pubitemid 46961920)
5. G. Burnstock, and V. Ralevic New insights into the local regulation of blood flow by perivascular nerves and endothelium Br. J. Plast. Surg. 47 1994 527 543
6. A. Cimini, E. Benedetti, L. Cristiano, P. Sebastiani, M.A. D'Amico, B. D'Angelo, and S. Di Loreto Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons Neuroscience 130 2005 325 337 (Pubitemid 40125471)
7. P.R. Colville-Nash, S.S. Qureshi, D. Willis, and D.A. Willoughby Inhibition of inducible nitric oxide synthase by peroxisome proliferator- activated receptor agonists: correlation with induction of heme oxygenase 1 J. Immunol. 161 1998 978 984 (Pubitemid 28323565)
8. L. del Campo, M. Ferrer, and G. Balfagon Hypertension alters the function of nitrergic and sensory innervation in mesenteric arteries from female rats Journal of Hypertension 27 2009 791 799
9. M. Ferrer, J. Marin, and G. Balfagon Diabetes alters neuronal nitric oxide release from rat mesenteric arteries Role of Protein Kinase C. Life Sci. 66 2000 337 345 (Pubitemid 30025486)
10. K. Goya, S. Sumitani, X. Xu, T. Kitamura, H. Yamamoto, S. Kurebayashi, H. Saito, H. Kouhara, S. Kasayama, and I. Kawase Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells Arterioscler. Thromb. Vasc. Biol. 24 2004 658 663 (Pubitemid 38451600)
11. S.M. Grundy, B. Howard, S. Smith Jr.; R. Eckel, R. Redberg, and R.O. Bonow Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association Circulation 105 2002 2231 2239 (Pubitemid 34517172)
12. I. Inoue, K. Shino, S. Noji, T. Awata, and S. Katayama Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells Biochem. Biophys. Res. Commun. 246 1998 370 374 (Pubitemid 28412605)
13. G.M. Keating, and K.F. Croom Fenofibrate: a review of its use in primary dyslipidaemia, the metabolic syndrome and type 2 diabetes mellitus Drugs 67 2007 121 153 (Pubitemid 46105094)
14. S. Kersten, B. Desvergne, and W. Wahli Roles of PPARs in health and disease Nature 405 2000 421 424 (Pubitemid 30367411)
15. A. Loesch Perivascular nerves and vascular endothelium: recent advances Histol. Histopathol. 17 2002 591 597 (Pubitemid 34411213)
16. I. Marquez-Rodas, F. Longo, R. Aras-Lopez, J. Blanco-Rivero, E. Dieguez, T. Tejerina, M. Ferrer, and G. Balfagon Aldosterone increases RAMP1 expression in mesenteric arteries from spontaneously hypertensive rats Regul. Pept. 134 2006 61 66
17. I. Marquez-Rodas, F.E. Xavier, I. Arroyo-Villa, F. Longo, R. Aras-Lopez, J. Blanco-Rivero, M. Ferrer, and G. Balfagon Increased expression in calcitonin-like receptor induced by aldosterone in cerebral arteries from spontaneously hypertensive rats does not correlate with functional role of CGRP receptor Regul. Pept. 146 2008 125 130
18. C.D. Meyers, and M.L. Kashyap Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies Curr. Opin. Cardiol. 20 2005 307 312 (Pubitemid 40896370)
19. E.K. Naderali, and S. Fatani The effects of fenofibrate on metabolic and vascular changes induced by chocolate-supplemented diet in the rat Eur. J. Pharmacol. 521 2005 99 104 (Pubitemid 41427796)
20. E.K. Naderali, S. Fatani, and G. Williams Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats Atherosclerosis 177 2004 307 312 (Pubitemid 39505262)
21. K.C. Nielsen, and C. Owman Contractile response and amine receptor mechanisms in isolated middle cerebral artery of the cat Brain Res. 27 1971 33 42
22. J.H. Parmentier, E.N. Lavrentyev, J.R. Falck, J.H. Capdevila, and K.U. Malik Evaluation of cytochrome P450 4 family as mediator of phospholipase D activation in aortic vascular smooth muscle cells Life Sci. 77 2005 1015 1029 (Pubitemid 40814637)
23. D.A. Playford, G.F. Watts, J.D. Best, and V. Burke Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus Am. J. Cardiol. 90 2002 1254 1257 (Pubitemid 35346887)
24. E. Sastre, I. Márquez-Rodas, J. Blanco-Rivero, and G. Balfagón Perivascular innervation of the superior mesenteric artery: pathophysiological implications Rev. Neurol. 50 2010 727 737
25. R. Simo, and C. Hernandez Advances in the medical treatment of diabetic retinopathy Diabetes Care 32 2009 1556 1562
26. A. Soria, M. del Carmen Gonzalez, H. Vidal, E. Herrera, and C. Bocos Triglyceridemia and peroxisome proliferator-activated receptor-alpha expression are not connected in fenofibrate-treated pregnant rats Mol. Cell. Biochem. 273 2005 97 107 (Pubitemid 40774761)